VÉSALE BIOSCIENCE

Press

O.A.G. (UK)

Vésale Bioscience, a pioneer in the development of innovative, personalized and sustainable phage-based therapy solutions for tackling superbugs and antimicrobial resistance.

L’Écho

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

La Libre

Vésale Bioscience enters into an innovative and ambitious collaboration with the Belgian Army

L’Écho

Vésale Bioscience raises a first tranche of €3 million: in preparation for its IPO, which has been brought forward to the end of 2022, Vésale Bioscience has raised a first tranche of funds from private investors.